Proteomics and Phosphoproteomics Profiling of Drug-Addicted BRAFi-Resistant Melanoma Cells-Reference-Cited by-同舟云学术

Proteomics and Phosphoproteomics Profiling of Drug-Addicted BRAFi-Resistant Melanoma Cells

Published:2021-08-03 Issue:9 Volume:20 Page:4381-4392
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Li Bohui¹²,Kong Xiangjun³,Post Harm¹²,Raaijmakers Linsey¹²,Peeper Daniel S.³,Altelaar Maarten¹²^ORCID

Affiliation:

1. Biomolecular Mass Spectrometry and Proteomics Group, Utrecht Institute for Pharmaceutical Science, Utrecht University, Utrecht 3584 CH, The Netherlands

2. Netherlands Proteomics Center, Padualaan 8, 3584 CH Utrecht, The Netherlands

3. Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands

Funder

China Scholarship Council

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.1c00331

Reference64 articles.

1. Mutations of theBRAFgene in human cancer, by Davieset al. (Nature2002; 417: 949-54)

2. Melanoma treatment in review

3. Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma

4. BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association

5. Many ways to resistance: How melanoma cells evade targeted therapies

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomics appending a complementary dimension to precision oncotherapy;Computational and Structural Biotechnology Journal;2024-12

2. Overcoming phenotypic switching: targeting protein-protein interactions in cancer;Exploration of Targeted Anti-tumor Therapy;2023-10-30

3. Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib;Biology;2023-04-17

4. Inferring kinase activity from phosphoproteomic data: Tool comparison and recent applications;Mass Spectrometry Reviews;2022-09-26